H.R.1839 - Medicaid Services Investment and Accountability Act of 2019116th Congress (2019-2020) |
|Sponsor:||Rep. Ruiz, Raul [D-CA-36] (Introduced 03/21/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||04/18/2019 Became Public Law No: 116-16. (All Actions)|
This bill has the status Became Law
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Became Law
Summary: H.R.1839 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (03/21/2019)
Medicaid Services Investment and Accountability Act of 2019
This bill alters several Medicaid programs and funding provisions.
For example, the bill temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services.
The bill also establishes a state Medicaid option to provide for medical assistance with respect to coordinated care provided through a health home (i.e., a designated provider or team of health-care professionals) for children with medically complex conditions. States must determine payment methodologies in accordance with specified requirements; payments also temporarily qualify for an enhanced federal matching rate.
Further, drug manufacturers with Medicaid rebate agreements for covered outpatient drugs must disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).